Orbenine (Cloxacillin Sodium)

Cloxacillin Sodium, the active ingredient in Orbenine, is a penicillinase‑resistant penicillin presented as an oral dosage form for oral use. It treats infections caused by β‑lactamase‑producing staphylococci and is prescribed for skin, bone, joint and respiratory tract infections in adults and children where appropriate.

GNH USA supplies Orbenine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orbenine (cloxacillin sodium) is used to treat bacterial infections that involve gram‑positive organisms, particularly staphylococci. - Skin and soft tissue infections: reduces bacterial load and promotes healing of cellulitis, impetigo and wound infections. - Bone and joint infections: eradicates staphylococcal osteomyelitis and septic arthritis. - Respiratory tract infections: treats pneumonia and bronchitis caused by susceptible strains. - Staphylococcal infections: effective against β‑lactamase‑producing Staphylococcus aureus in various clinical sites.

Adverse reactions may occur with any antibiotic therapy. Monitoring for side effects is recommended.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Rash: erythematous skin eruption. - Elevated liver enzymes: transient increase in hepatic transaminases. - Headache: mild tension‑type headache. - Taste disturbance: altered taste perception.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Stevens‑Johnson syndrome: rare mucocutaneous blistering disorder. - Clostridioides difficile colitis: severe diarrhea due to bacterial overgrowth. - Hepatotoxicity: significant liver injury with jaundice. - Neutropenia: marked reduction in white blood cells. - Hemolytic anemia: destruction of red blood cells.

Before initiating therapy, consider patient‑specific factors and monitor for adverse events. - Allergy assessment: confirm no known hypersensitivity to penicillins or β‑lactam antibiotics. - Renal function: adjust dose in patients with impaired kidney clearance. - Hepatic monitoring: check liver enzymes in prolonged therapy. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Drug interactions: review concomitant medications for potential interactions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Cloxacillin may alter the pharmacokinetics or pharmacodynamics of several agents.

Major Interactions (Avoid): - Probenecid: reduces renal excretion, increasing cloxacillin plasma levels. - Methotrexate: may enhance methotrexate toxicity by reducing clearance. - Live vaccines: concurrent use can diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease hormonal effectiveness, consider backup contraception. - Warfarin: potential increase in INR, monitor coagulation parameters. - Aminoglycosides: additive nephrotoxicity risk, observe renal function. - Tetracyclines: antagonistic effect on bacterial killing, assess clinical response. - NSAIDs: may increase risk of renal impairment, especially in dehydrated patients.